These compounds may interact with:
Mannose-6-phosphate isomerase
Potentially involved in: congenital disorder of glycosylation; protein-losing enteropathy; cutaneous leishmaniasis; galactosemia; hepatic fibrosis, congenital; diarrhea; factor xi deficiency; hepatomegaly; hypoglycemia; liver cirrhosis; lymphedema; muscle hypotonia; protein-losing enteropathies; vomiting; liver failure; failure to gain weight; fibrosis, liver; hypoalbuminemia; lymphatic obstruction; villous atrophy of intestine
Disease data sourced from Pharos.